Aimei Health Technology Co., Ltd (NASDAQ: AFJK) closed its initial public offering of 6.9 million units at $10 each, including the full exercise of the underwriters’ option to purchase up to an additional 900,000 units to cover over-allotments.
Each unit consists of one ordinary share and one right. Each right entitles the holder to receive one-fifth of a share upon the consummation of an initial business combination.
The units list on the Nasdaq under the ticker symbol AFJKU. Once the securities begin separate trading, shares and rights are expected to list under the symbols AFJK and “AFJKR.
The SPAC is focused on small-cap healthcare businesses.
Spartan Capital Securities was sole book running manager. Loeb & Loeb is legal counsel to the company. Hunter, Taubman Fischer & Li is legal counsel to Spartan Capital Securities. Ogier is serving as Cayman Islands legal counsel to the company.
ARC Group Limited acted as financial advisor. Read more.
